Premenopausal women affected by sexual arousal disorder treated with sildenafil: A double-blind, cross-over, placebo-controlled study

British Journal of Obstetrics and Gynaecology

Volumn 108, Issue 6, 2001, Pages 623-628

  Caruso, Salvatore ^a   Intelisano, Giorgia ^b   Lupo, Lorenzo ^b   Agnello, Carmela ^b  

^a Ospedale S Bambino   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; SILDENAFIL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; PREMENOPAUSE; PSYCHOSEXUAL DISORDER; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PREMENOPAUSE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 0035380684     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-5456(00)00143-1     Document Type: Article

References (35)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.
2. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association, 1994.
3. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. Geneva: WHO, 1992.
4. Masters WH, Johnson VE. Human Sexual Response. Boston: Little Brown, 1966.
5. Masters WH, Johnson VE. Human Sexual Inadequacy. Boston: Little Brown, 1970.
6. Kaplan HS. Disorders of Sexual Desire. New York: Brunner/Mazel, 1979.
7. Rosen RC, Phillips NA, Gendrano NC 3rd NC, Ferguson DM. Oral phentolamine and female sexual arousal disorder: a pilot study. J Sex Marital Ther 1999;25:137-144.
8. Meston CM, Heiman Jr. Ephedrine-activated physiological sexual arousal in women. Arch Gen Psychiatry 1998;55:652-656.
9. Schulz WW, van Andel P, Sabelis I, Mooyaart E. Magnetic resonance imaging of male and female genitals during coitus and female sexual arousal. BMJ 1999;319:1596-1600.
10. Sadeghi-Nejad H, Moreland RB, Traish AM, Nehra A, Azadzoi KM, Goldstein I. Preliminary report on the development and characterization of rabbit clitoral smooth muscle cell culture. Int J Impot Res 1998;10:165-169.
11. Levin RJ. The physiology of sexual function in women. Clin Obstet Gynaecol 1980;7:213-252.
12. Argiolas A. Neuropeptides and sexual behaviour. Neurosci Biobehav Rev 1999;23:1127-1142.
13. Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, Azadzoi KM. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectly insufficiency. Int J Impot Res 1997;9:27-37.
14. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectly insufficiency syndromes. Int J Impot Res 1998;10:84-90.
15. Williams-Ashman HG, Reddi AH. Differentiation of mesenchymal tissues during phallic morphogenesis with emphasis on the penis: role of androgens and other regulatory agents. J Ster Bioch Mol Biol 1991;39:873-881.
16. Van Turnhout AA, Hage JJ, van Diest PJ. The female corpus spongiosum revisited. Acta Obstet Gynecol Scand 1995;74:767-771.
17. Baskin IS, Erol A, Li YW, Liu WH, Kurzrock E, Cunha GR. Anatomical studies of the human clitoris. J Urol 1999;162(3Pt2):1015-1020.
18. Levin RJ. The mechanisms of female sexual arousal. Ann Rev Sex Res 1992;3:1-6.
19. Lavoisier P, Aloui R, Schmidt MH, Watrelot A. Clitoral blood flow increases following vaginal pressure stimulation. Arch Sex Behav 1995;24:3745.
20. Ingelman-Sundberg A. The anterior vaginal wall as an organ for the transmission of active forces to the urethra and the clitoris. Int Urogynecol J Pelvic Floor Dysfunct 1997;8:50-51.
21. Toesca A, Stolfi VM, Cocchia D. Immunohistochemical study of the corpora cavernosa of the human clitoris. J Anat 1996;188:513-520.
22. Aboseif SR, Lue TF. Hemodynamic of penile erection. Urol Clin N Amer 1988;15:1-7.
23. Hauser-Kronberger C, Cheung A, Hacker GW, Graf AH, Dietze O, Frick J. Peptidergic innervation of the human clitoris. Peptides 1999;20:539-543.
24. Moreland RB, Goldstein I, Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernousum smooth muscle cells. Life Sci 1998;62(20):309-318.
25. Park K, Moreland RB, Goldstein I, Atala A, Traish A. Sildenafil inhibits Phosphodiesterase type 5 in human clitoral corpus cavernousum smooth muscle. Biochem Biophys Res Commun 1998;249:612-617.
26. Nurnberg HG, Lauriello J, Hensley PL, Parker LM, Keith SJ. Sildenafil for iatrogenic serotoninergic antipressant medication-induced sexual dysfunction in 4 patients. J Clin Psychiatry 1999; 60:33-35.
27. Rosenberg KP, Sildenafil J. Sex Marital Ther 1999;25:271-279.
28. Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Immunohistochemical description of nitric oxide syntheses isoforms in human clitoris. J Urol 1997;158:75-78.
29. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral Sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-1404.
30. McCoy NL, Matyas JR. Oral contraceptives and sexuality in university women. Arch Sex Behav 1996;25:73-79.
31. Dennerstein L, Duldey EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas 1997;26:83-93.
32. Glantz SA. Primer of Biostatistics. New York: McGraw-Hill Inc, 1997.
33. Kaplan SA, Reis RB, Kohn IJ, et al. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999;53: 481-488.
34. Casson PR, Elkind-Hirsch KE, Buster JE, Hornsby PJ, Carson SA, Snabes MC. Effect of postmenopausal oestrogen replacement on circulating androgen. Obstet Gynecol 1997;90:995-998.
35. Basson R, Berman J, Burnet A, et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000;163:888-893.